about
Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneityThe role of CD95 and CD95 ligand in cancerCD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cellsCD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon Response.In vivo Effects in Melanoma of ROCK Inhibition-Induced FasL Overexpression.CD95 ligand induces senescence in mismatch repair-deficient human colon cancer via chronic caspase-mediated induction of DNA damage.Cancer Stem Cells and Their Microenvironment: Biology and Therapeutic Implications.CD95 Signaling Inhibits B Cell Receptor-Mediated Gammaherpesvirus Replication in Apoptosis-Resistant B Lymphoma Cells.Many si/shRNAs can kill cancer cells by targeting multiple survival genes through an off-target mechanismActivation of Fas/FasL pathway and the role of c-FLIP in primary culture of human cholangiocarcinoma cells.Induction of DISE in ovarian cancer cells in vivo.Identification of DISE-inducing shRNAs by monitoring cellular responses.New Advances and Challenges of Targeting Cancer Stem Cells.DISE: A Seed-Dependent RNAi Off-Target Effect That Kills Cancer Cells.6mer seed toxicity in tumor suppressive microRNAsPlasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to ResistanceAspirin cooperates with p300 to activate the acetylation of H3K9 and promote FasL-mediated apoptosis of cancer stem-like cells in colorectal cancer
P2860
Q26796292-7730EEF9-9025-4ACB-BEE1-ACAAF0077C59Q26995847-1EC109B1-8943-46AF-9E06-5F6FD2BB3F0DQ27329081-AAD7B038-DD76-4F8F-90F5-C81B28CAF721Q33809161-6B2EC56F-9249-4E95-98A8-8F7637A63F70Q35847696-FEDCA340-1856-43E7-A9CD-FD1976327411Q37745587-4633D52C-96E1-400E-99BB-8D805F16E6CEQ39197682-5144E4F7-128E-46E4-8C3A-C0D3A03EDAD2Q40563964-276075ED-9FAC-4914-AE36-F09BB8526EEBQ42637848-157AC909-6532-4F32-B014-B440A46DF2C4Q43185882-A73B5A62-7AE5-4091-B45A-7B5B55E588DFQ47095279-6935BB2A-7B0C-4C15-BD0D-17E3045CB632Q47675158-F886F32E-30F1-47A5-86E5-179254154791Q48588244-76B993B5-1CCC-4EE2-80A3-0CC69B706D92Q50138597-6C770A04-A3B7-4FB5-8A77-2DD122CB6329Q58105685-97BE0747-596F-482A-BBFE-89763ED37002Q58729482-CEB513FB-5371-4BDE-9850-D1F04F46361BQ58796715-3FD3DC80-1E1C-4B55-B6AF-2D301E169DB7
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
CD95 and CD95L promote and protect cancer stem cells
@ast
CD95 and CD95L promote and protect cancer stem cells
@en
type
label
CD95 and CD95L promote and protect cancer stem cells
@ast
CD95 and CD95L promote and protect cancer stem cells
@en
prefLabel
CD95 and CD95L promote and protect cancer stem cells
@ast
CD95 and CD95L promote and protect cancer stem cells
@en
P2093
P2860
P356
P1476
CD95 and CD95L promote and protect cancer stem cells
@en
P2093
Abbas Hadji
Abhinandan Pattanayak
Andrea E Murmann
Annika Hau
Frederick J Kohlhapp
Huiping Liu
Paolo Ceppi
P2860
P2888
P356
10.1038/NCOMMS6238
P407
P577
2014-11-04T00:00:00Z